Evidence map›Paper›PMID 24878957›Full record

ArticleThe Journal of biological chemistry2014

The U3 region of Moloney murine leukemia virus contains position-independent cis-acting sequences involved in the nuclear export of full-length viral transcripts.

Natalia A Volkova, Elena G Fomina, Viktoryia V Smolnikova, Natalia A Zinovieva, Igor K Fomin

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Generation of High-Titer Self-Inactivated γ-Retroviral Vector Producer Cells.Molecular therapy. Methods & clinical development · 2019
    Article
  3. Genetic Strategies for HIV Treatment and Prevention.Molecular therapy. Nucleic acids · 2018
    Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Natalia A VolkovaFrom the The Laboratory of Cellular Engineering, All-Russian State Research Institute of Animal Breeding, 142132 Moscow region, Russia.
Elena G FominaThe Laboratory for Biotechnology and Immunodiagnosis, The Republic Research and Practical Center for Epidemiology and Microbiology, 220114 Minsk, Belarus, and.
Viktoryia V SmolnikovaThe Republic Center of Hematology and Bone Marrow Transplantation, 220116 Minsk, Belarus.
Natalia A ZinovievaFrom the The Laboratory of Cellular Engineering, All-Russian State Research Institute of Animal Breeding, 142132 Moscow region, Russia, n_zinovieva@mail.ru.
Igor K FominFrom the The Laboratory of Cellular Engineering, All-Russian State Research Institute of Animal Breeding, 142132 Moscow region, Russia, ikfomin@mail.ru.
Belarusian Research Center For Pediatric Oncology and Hematology · BY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The distinguishing feature of self-inactivating (SIN) retroviral vectors is the deletion of the enhancer/promoter sequences in the U3 region of the 3' long terminal repeat. This design is used to overcome transcriptional interference and prevent downstream transcription from the 3' long terminal repeat. SIN vectors were derived from a number of different retroviruses. Studies of SIN vectors show that extensive U3 deletions in HIV-based vectors do not alter viral titers or the in vitro and in vivo properties of the vectors. However, deletion of the U3 sequences in γ- and α-retroviruses correlates with defects in 3' RNA processing and reduces viral titers by >10-fold. Here, we studied the steps in the retroviral life cycle that are affected by the deletion of sequences in the 3' U3 region of Moloney murine leukemia virus-derived retroviral vectors. The results show that the amounts of both full-length and internal RNA transcripts of U3-minus vectors are reduced in the nuclei of transfected cells, an effect that is probably due to a general defect in 3' RNA processing. Furthermore, full-length RNA transcripts were also defective in terms of nuclear export. This defect was complemented by transferring the U3 region to another position within the retroviral vector, indicating that the U3 region contains position-independent cis-acting sequences that are required for the transport of full-length viral transcripts. The results also suggest that the leader region of Moloney murine leukemia virus contains inhibitory/regulatory sequences, which prevent export and mediate nuclear retention of full-length viral RNA.

Indexed as

Terminal Repeat SequencesActive Transport, Cell NucleusAnimalsEnhancer Elements, GeneticGene ExpressionGenetic VectorsMiceMoloney murine leukemia virusNIH 3T3 CellsPromoter Regions, GeneticRNA Processing, Post-TranscriptionalRNA, ViralSequence DeletionTransfectionVirus ReplicationRNA, ViralFull-length Viral RNANuclear RNA ExportRetrovirusRNARNA TransportSelf-inactivating VectorsU3 RegionViral ReplicationViral Transcription

Identifiers

PMID24878957
PMCPMC4106331
OpenAlexW2014585725

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.